It has been well reported that angiogenesis is involved in cancer development in the processes of endothelial cell proliferation, migration, and invasion.4 The vascular endothelial growth factor (VEGF) family is the essential antitumor angiogenesis target in both non‐small cell lung cancer and SCLC. The gene discussed is VEGFA; the disease is small cell lung carcinoma.